Gene for Cholesterol and Cardiovascular Disease Identified through Genome Scan

facebook twitter google print email
Media Contact:Jessica Mikulski | | 215-349-8369August 4, 2010

Researchers at the University of Pennsylvania School of Medicine, the Broad Institute, Massachusetts General Hospital, and Alnylam Pharmaceuticals Inc., are some of the first to prove that a gene linked to a disease trait by genome wide association studies (GWAS) can be clinically relevant and an important determinant of disease risk.

Click here to view the full release.

Multimedia